Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.
about
Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study GroupTherapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitisEvaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates.Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children witDescription of two new isolates of Streptococcus pneumoniae in spain that are highly resistant to cefotaxime.Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.Management of infections due to antibiotic-resistant Streptococcus pneumoniaeSusceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance studyKilling activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically acAntibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers.Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitisGenetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeBactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolatesIdentification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States.Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong.High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporinsAntimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeCefotaxime breakpoint for Streptococcus pneumoniae.Activity of vancomycin, teicoplanin and cephalosporins against penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae.Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxoneIncreased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use.Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniaeDetection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test.Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniaeScreening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran.
P2860
Q28367896-386DF79F-EFCF-4B7A-9627-D61AF8166D11Q33654490-F6226CAB-C0C1-4CE4-80E1-1AE045AE9F6BQ33659832-1524DB81-9E6D-4047-ADD8-DF5472582B97Q33672446-D85D497C-ED86-4A12-AA7E-37120671C966Q33692927-527585DD-FDA2-4AC9-A2F6-49CE5009ED5FQ33700428-E4C64AEC-0C5F-4BB6-AA5D-4BC546AAAEF6Q33753762-77A01A69-A32C-4DF2-A074-CB0CBE206AEEQ33963714-9836572E-10CC-49AA-B984-D41428488AF1Q33975374-75C67A06-4E8F-4EB9-8A27-67AC24543A46Q33977347-081A8D87-5699-4521-A406-DBB50F401591Q33977786-03FFBDB1-4789-49DB-BEF4-5AF8202A57E0Q33979847-8E63D17C-8287-49FE-9D64-AB5940C83A15Q35013994-FFBE99AF-0F2E-432D-9938-C0EFDF25A932Q35115272-28624670-FA41-470C-AF3C-6D93653A1A57Q35116103-A72562C0-5571-4C38-8425-F30C2329E7ABQ35117123-29CF3A4A-59C3-451F-A70C-5FD2A1260EF1Q35118221-ADBF52D0-3FFD-416C-B69D-0BA06645C762Q35119049-842C08D8-A13D-4F71-A78D-D9E605D2163AQ35119197-416F1AB2-5D1E-45CF-A8DB-1A1EB0CD0CF9Q35119679-F7F4F4B3-3571-48B0-A7E3-82B2E4BC179EQ35120392-19171F2F-DF38-4CA4-B1F9-1409FE5C00C0Q35120738-29CFC081-D56C-4021-A312-E84F9B7D2C0BQ35122014-4AC25A72-B8BE-460D-94FF-0F93E232F41CQ35124415-3CF73841-C88C-42F3-A8A1-F65EA2305222Q35126617-FB2A5C21-9A0E-48B4-8CB3-567EC3B8040FQ35810802-015594F9-86DE-4732-9F2F-3D7EE670B7E5Q35816735-BD0E3580-857E-45E1-B7B4-F720E9AEAAC5Q35817800-8C0B697D-BFC7-4B62-8C6D-53D721D0B4E2Q35820094-27D73531-2902-4F75-953A-ED8E82BB8F9CQ35821585-8BCB94AB-5898-4965-8AA7-B166095D0757Q35822592-56FD1680-24EF-45CE-A33F-CFC24C4DF389Q35823422-26A6605E-FFD4-4ED0-BC42-36BA80C7E41EQ35894130-6625E3CC-F16D-4A12-A96B-F45A169FB7B5Q36540874-8777E812-4439-4D80-A1CB-F7D13E3B0D5DQ37070023-A5B3C341-193E-461A-958A-CD1A459FBD29Q37071655-3C520196-AD18-4FF8-BFAA-25014DFB49C2Q37074532-C80B41D7-1470-4540-8893-7085328C98F5Q37093797-79C7E667-BCC2-40E8-A2AD-367D28770D55Q37128713-FAA9CE19-721F-448E-9B9F-5B6C6714D0C8Q38257352-E55A6CB6-186D-452C-A4A2-C21A6859DCF0
P2860
Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@en
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@nl
type
label
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@en
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@nl
prefLabel
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@en
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@nl
P1476
Ceftriaxone failure in meningi ...... ty to beta-lactam antibiotics.
@en
P2093
P304
P577
1991-11-01T00:00:00Z